Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis.
Where this comes from
- Record sourced from PubMed, PMID 8017896.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Magnetic resonance imaging (MRI) provides an objective method of evaluating multiple sclerosis clinical trials and is at least five times more sensitive to disease activity. In a recent clinical trial, MRI was also approximately twice as sensitive as clinical measurements to the treatment effect of a drug.
Medical subject headings
- Brain
- Clinical Trials as Topic
- Magnetic Resonance Imaging
- Multiple Sclerosis